Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 1
1916 1
1917 1
1921 2
1924 1
1930 2
1937 1
1939 1
1942 2
1944 1
1945 1
1947 2
1949 1
1955 1
1956 1
1957 2
1958 1
1959 1
1963 1
1970 2
1971 1
1974 1
1977 3
1978 4
1979 5
1980 1
1981 1
1982 1
1983 6
1984 9
1985 4
1986 2
1987 1
1988 4
1989 6
1990 3
1991 3
1992 2
1993 7
1994 3
1995 6
1996 3
1997 3
1998 3
1999 3
2000 4
2001 2
2002 3
2003 4
2004 11
2005 7
2006 11
2007 6
2008 14
2009 11
2010 20
2011 33
2012 20
2013 17
2014 15
2015 33
2016 10
2017 21
2018 18
2019 25
2020 21
2021 44
2022 33
2023 40
2024 35
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Results by year

Filters applied: . Clear all
Page 1
Common questions and misconceptions about caffeine supplementation: what does the scientific evidence really show?
Antonio J, Newmire DE, Stout JR, Antonio B, Gibbons M, Lowery LM, Harper J, Willoughby D, Evans C, Anderson D, Goldstein E, Rojas J, Monsalves-Álvarez M, Forbes SC, Gomez Lopez J, Ziegenfuss T, Moulding BD, Candow D, Sagner M, Arent SM. Antonio J, et al. Among authors: gibbons m. J Int Soc Sports Nutr. 2024 Dec;21(1):2323919. doi: 10.1080/15502783.2024.2323919. Epub 2024 Mar 11. J Int Soc Sports Nutr. 2024. PMID: 38466174 Free PMC article. Review.
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial.
Maher TM, Tudor VA, Saunders P, Gibbons MA, Fletcher SV, Denton CP, Hoyles RK, Parfrey H, Renzoni EA, Kokosi M, Wells AU, Ashby D, Szigeti M, Molyneaux PL; RECITAL Investigators. Maher TM, et al. Among authors: gibbons ma. Lancet Respir Med. 2023 Jan;11(1):45-54. doi: 10.1016/S2213-2600(22)00359-9. Epub 2022 Nov 11. Lancet Respir Med. 2023. PMID: 36375479 Free article. Clinical Trial.
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Among authors: gibbons ma. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: gibbons ma. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T. Mackinnon AC, et al. Among authors: gibbons ma. Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46. doi: 10.1164/rccm.201106-0965OC. Epub 2011 Nov 17. Am J Respir Crit Care Med. 2012. PMID: 22095546 Free PMC article.
Common Questions and Misconceptions About Energy Drinks: What Does the Scientific Evidence Really Show?
Antonio J, Antonio B, Arent SM, Candow DG, Escalante G, Evans C, Forbes S, Fukuda D, Gibbons M, Harty P, Jagim AR, Kalman DS, Kerksick CM, Kurtz JA, Lillis J, Lowery L, Mastrofini GF, Mills S, Nelson M, Pereira F, Roberts J, Sagner M, Stout J, Tartar J, Wells A. Antonio J, et al. Among authors: gibbons m. Nutrients. 2024 Dec 27;17(1):67. doi: 10.3390/nu17010067. Nutrients. 2024. PMID: 39796501 Free PMC article. Review.
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
Al-Shahi Salman R, Dennis MS, Sandercock PAG, Sudlow CLM, Wardlaw JM, Whiteley WN, Murray GD, Stephen J, Rodriguez A, Lewis S, Werring DJ, White PM; RESTART Collaboration. Al-Shahi Salman R, et al. JAMA Neurol. 2021 Oct 1;78(10):1179-1186. doi: 10.1001/jamaneurol.2021.2956. JAMA Neurol. 2021. PMID: 34477823 Free PMC article. Clinical Trial.
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
Schroth M, Deans J, Arya K, Castro D, De Vivo DC, Gibbons MA, Ionita C, Kuntz NL, Lakhotia A, Neil Knierbein E, Scoto M, Sejersen T, Servais L, Tian C, Waldrop MA, Vázquez-Costa JF. Schroth M, et al. Among authors: gibbons ma. Neurol Clin Pract. 2024 Aug;14(4):e200310. doi: 10.1212/CPJ.0000000000200310. Epub 2024 May 24. Neurol Clin Pract. 2024. PMID: 38915908 Free PMC article.
Ecology of Rhizostomeae.
Thibault D, Kuplik Z, Prieto L, Enrique-Navarro A, Brown M, Uye S, Doyle T, Pitt K, Fitt W, Gibbons M. Thibault D, et al. Among authors: gibbons m. Adv Mar Biol. 2024;98:397-509. doi: 10.1016/bs.amb.2024.07.008. Epub 2024 Aug 30. Adv Mar Biol. 2024. PMID: 39547753 Review.
547 results